Cargando…

An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancer

BACKGROUND: Cancer cells release heterogeneous populations of extracellular vesicles (EVs) that transmit aggressive phenotypic traits to recipient cells. We aimed to establish if the heterogenous EVs population or a sub-population is responsible, if we could block undesirable cell-to-cell communicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	McNamee, Niamh, Catalano, Mariadelva, Mukhopadhya, Anindya, O’Driscoll, Lorraine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339474/ https://www.ncbi.nlm.nih.gov/pubmed/37442985 http://dx.doi.org/10.1186/s12885-023-11160-2

Ejemplares similares

Inhibiting extracellular vesicles formation and release: a review of EV inhibitors
por: Catalano, Mariadelva, et al.
Publicado: (2019)

Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles
por: Mukhopadhya, Anindya, et al.
Publicado: (2023)

A method of separating extracellular vesicles from blood shows potential clinical translation, and reveals extracellular vesicle cargo gremlin-1 as a diagnostic biomarker
por: McNamee, Niamh, et al.
Publicado: (2021)

Extracellular vesicle separation from milk and infant milk formula using acid precipitation and ultracentrifugation
por: Mukhopadhya, Anindya, et al.
Publicado: (2021)

Extracellular vesicles report on the MET status of their cells of origin regardless of the method used for their isolation
por: Useckaite, Zivile, et al.
Publicado: (2020)

Proteomics profiling identifies extracellular vesicles’ cargo associated with tumour cell induced platelet aggregation
por: McNamee, Niamh, et al.
Publicado: (2022)

2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype
por: O’Neill, Sadhbh, et al.
Publicado: (2019)

Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment
por: O’Driscoll, Lorraine
Publicado: (2020)

miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
por: O'Brien, Keith, et al.
Publicado: (2015)

Evidence for the Need to Evaluate More Than One Source of Extracellular Vesicles, Rather Than Single or Pooled Samples Only, When Comparing Extracellular Vesicles Separation Methods
por: Martinez-Pacheco, Sarai, et al.
Publicado: (2021)

Mesenchymal Stem Cell Derived Extracellular Vesicles for Tissue Engineering and Regenerative Medicine Applications
por: Tsiapalis, Dimitrios, et al.
Publicado: (2020)

Exercise Training and Circulating Small Extracellular Vesicles: Appraisal of Methodological Approaches and Current Knowledge
por: Darragh, Ian A. J., et al.
Publicado: (2021)

Applications of Extracellular Vesicles in Triple-Negative Breast Cancer
por: St-Denis-Bissonnette, Frederic, et al.
Publicado: (2022)

A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos
por: Rankin-Turner, Stephanie, et al.
Publicado: (2021)

ISEV position paper: extracellular vesicle RNA analysis and bioinformatics
por: Hill, Andrew F., et al.
Publicado: (2013)

Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer
por: Dong, Menglu, et al.
Publicado: (2022)

Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles
por: Martinez, Vanesa G., et al.
Publicado: (2017)

Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential
por: Das, Kaushik, et al.
Publicado: (2023)

The roles of small extracellular vesicles as prognostic biomarkers and treatment approaches in triple-negative breast cancer
por: Zhou, Yueyuan, et al.
Publicado: (2022)

Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteers
por: Jakate, Abhijeet, et al.
Publicado: (2019)

Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles
por: Kannan, Anbarasu, et al.
Publicado: (2019)

Lipidomic Analysis of Cells and Extracellular Vesicles from High- and Low-Metastatic Triple-Negative Breast Cancer
por: Nishida-Aoki, Nao, et al.
Publicado: (2020)

Eribulin and Paclitaxel Differentially Alter Extracellular Vesicles and Their Cargo from Triple-Negative Breast Cancer Cells
por: Pederson, Petra J., et al.
Publicado: (2021)

Extracellular Vesicle-Mediated Purinergic Signaling Contributes to Host Microenvironment Plasticity and Metastasis in Triple Negative Breast Cancer
por: Duan, Suzann, et al.
Publicado: (2021)

Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells
por: Yi, Yong Weon
Publicado: (2023)

Transcriptome of Extracellular Vesicles Released by Hepatocytes
por: Royo, Felix, et al.
Publicado: (2013)

Human bone marrow stem/stromal cell osteogenesis is regulated via mechanically activated osteocyte‐derived extracellular vesicles
por: Eichholz, Kian F., et al.
Publicado: (2020)

Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles
por: Witwer, Kenneth W, et al.
Publicado: (2021)

Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells
por: Kavanagh, E L, et al.
Publicado: (2017)

Author Correction: Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles
por: Kannan, Anbarasu, et al.
Publicado: (2020)

The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs)
por: Howard, Jane, et al.
Publicado: (2021)

Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient
por: Vannini, Ivan, et al.
Publicado: (2022)

Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome
por: Tkach, Mercedes, et al.
Publicado: (2022)

Small Extracellular Vesicles from Hypoxic Triple-Negative Breast Cancer Cells Induce Oxygen-Dependent Cell Invasion
por: Pachane, Bianca Cruz, et al.
Publicado: (2022)

The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance
por: Breslin, Susan, et al.
Publicado: (2016)

The future of Extracellular Vesicles as Theranostics – an ISEV meeting report
por: Soekmadji, Carolina, et al.
Publicado: (2020)

Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells
por: Ozawa, Patricia Midori Murobushi, et al.
Publicado: (2018)

Inhibitors of Bacterial Extracellular Vesicles
por: Chen, Jianwei, et al.
Publicado: (2022)

Molecular Determinants for RNA Release into Extracellular Vesicles
por: Mosbach, Marie-Luise, et al.
Publicado: (2021)

Profiling mitochondrial DNA mutations in tumors and circulating extracellular vesicles of triple‐negative breast cancer patients for potential biomarker development
por: Vikramdeo, Kunwar Somesh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tnfqtbl4pjj4rg2tt034lpi92t